Positive House Dust Mite Immunotherapy Results for UK Biotech – Labiotech.eu (blog)
Proactive Investors UK |
Positive House Dust Mite Immunotherapy Results for UK Biotech
Labiotech.eu (blog) British biotech Allergy Therapeutics reports positive early-stage results for its house dust mite immunotherapy. It’s been a good month for Allergy Therapeutics, which also reported positive Phase II results for its grass pollen allergy vaccine trial … Aimmune Therapeutics (AIMT) Announces Data on Terminology Used with Oral Immunotherapy Were Presented at …StreetInsider.com Allergy Therapeutics plc – Positive new data with house-dust mite immunotherapyNasdaq Allergy Therapeutics plc – Positive new data with house-dust mite …GlobeNewswire (press release) Shares magazine –Proactive Investors UK –DirectorsTalk Interviews all 7 news articles » |
FierceBiotech |
Looking to unseat Sanofi and Shire drugs, Atlas gene therapy startup Avrobio files for $86M IPO
FierceBiotech The offering would give the Atlas Venture-backed startup the means to run clinical trials of gene therapies designed to supplant enzyme replacement therapies from Sanofi, Shire and Pfizer. Cambridge, Massachusetts-based Avrobio’s approach entails … |
www.oncnursingnews.com/ |
Monitoring Adverse Effects of Immunotherapy
www.oncnursingnews.com/ Cancer immunotherapies are a promising development, but taking care of patients who are using these drugs can be a challenge for oncology nurses. After all, it isn’t exactly easy to monitor patients for adverse effects (AEs) that could arise in any of … |